tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
Advertisement

Xeris Pharmaceuticals (XERS) Revenue

Compare
1,038 Followers

Xeris Pharmaceuticals Revenue

Xeris Pharmaceuticals had a revenue of 71.54M in the quarter ending Jun 30, 2025, with 19.00%. This bring the company's revenue in the last twelve months to 246.03M, Decreased 10.55%. In the fiscal year ending Dec 31, 2024, Xeris Pharmaceuticals had annual revenue of 203.07M with 23.89% growth.
Revenue (ttm)
246.03M
Revenue Growth
35.62%
P/S Ratio
6.23
Revenue/Employee
$515,406
Employees
394
Market Cap
$1.26B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
203.07M39.16M+23.89%
Dec 31, 2023
163.91M0.000.00%
Dec 31, 2023
163.91M0.000.00%
Dec 31, 2023
163.91M0.000.00%
Dec 31, 2023
163.91M53.67M+48.68%
Dec 31, 2022
110.25M60.66M+122.32%
Dec 31, 2021
49.59M0.000.00%
Dec 31, 2020
49.59M47.13M+1,911.76%
Dec 31, 2019
2.46M-17.69M-87.77%
Dec 31, 2019
20.16M18.60M+1,195.31%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis